Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead?

Nobody can predict the future, but it's not hard to imagine increasing pharmaceutical sales. In 2022, prescription drug spending in the U.S. climbed more than ... Read more

Bron:

Fool.com: The Motley Fool